title: Pegfilgrastim plus AMD 3100 for stem-cell mobilization in children.
authors.forename: Charlotte
authors.initials: C
authors.lastname: Cardenoux
authors.forename: François
authors.initials: F
authors.lastname: Deméocq
authors.forename: Justyna
authors.initials: J
authors.lastname: Kanold
authors.forename: Etienne
authors.initials: E
authors.lastname: Merlin
authors.forename: Caroline
authors.initials: C
authors.lastname: Oudot
authors.forename: Christophe
authors.initials: C
authors.lastname: Piguet
authors.forename: Marie-Claire
authors.initials: MC
authors.lastname: Roussanne
mesh_terms: D001596:Benzylamines; D002528:Cerebellar Neoplasms / Q000628:therapy*; D002648:Child; D000080027:Cyclams; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage*; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D006571:Heterocyclic Compounds / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008527:Medulloblastoma / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods*; D011092:Polyethylene Glycols; D011994:Recombinant Proteins
chemical_list: D001596:Benzylamines; D000080027:Cyclams; D006571:Heterocyclic Compounds; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; C455861:pegfilgrastim; D011092:Polyethylene Glycols; D000069585:Filgrastim; C088327:plerixafor